Vito Mangiardi

Vito Mangiardi

Founder and Chairman of the Board of Directors

Vito is a senior executive with more than 20 years of experience as CEO, COO and President of various companies in the life sciences product and service industries. These companies were focused in pharmaceutical drug development, clinical research, clinical trials and clinical diagnostics as well as bioenergy. With decades of experience driving P&L performance, he is seasoned in general management, operations, marketing strategy and science, having led corporate strategy, operations, sales, marketing, business management and research & development.

Vito has held positions as Executive VP and COO for Quintiles Transnational, President of AAI Pharma, President and CEO of Diagnostics Laboratories, Inc., Clingenix, Inc., Bilcare, Inc., and Sales/Marketing Director for Baxter Travenol Clinical Assays Division.

More recently, Vito served as the COO/Deputy Director of Operations and Production at the University of California Lawrence Berkeley National Laboratory Joint Genome Institute where he implemented four bio-energy programs to enhance the production of biofuels utilizing biomass. During his tenure, Vito served as Chairman of the Operations Management Team and was appointed Senior Member of the Joint Management Board and the Strategic Management Team.

With international experience leading and managing organizations on four continents, Vito has led companies of every size, from start-ups to mid-size and mature companies. He is a critical thinker in organizational management and has led alliances, acquisitions, due diligence and integration projects. Vito has been on the Board of Directors of four companies and has proven success in raising funds globally.

Vito started his career as a Research Clinical Chemist and Technology Development Manager with Bio-Rad and developed an antigen-antibody separation technology and clinical products in several therapeutic areas during his tenure. The three U.S. patents he holds, together with his R&D contributions, helped establish the company as a market leader in hematology and thyroid testing.